Change in effectiveness of sotrovimab for preventing hospitalization and mortality for at-risk COVID-19 outpatients during an Omicron BA.1 and BA.1.1-predominant phase
暂无分享,去创建一个
A. Ginde | M. Wynia | N. Aggarwal | T. Bennett | S. Russell | L. Beaty | Kyle C. Molina | D. Mayer | N. Carlson | Jennifer Peers | Jennifer L. Peers